Propafenone
- Generic Name
- Propafenone
- Brand Names
- Rythmol
- Drug Type
- Small Molecule
- Chemical Formula
- C21H27NO3
- CAS Number
- 54063-53-5
- Unique Ingredient Identifier
- 68IQX3T69U
Overview
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated.
Background
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated.
Indication
Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.
Associated Conditions
- Atrial Fibrillation
- Paroxysmal Atrial Fibrillation (PAF)
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Ventricular Arrhythmia
Clinical Trials
FDA Approved Products
Propafenone
Manufacturer:Rebel Distributors Corp
Route:ORAL
Strength:325 mg in 1 1
Approved: 2011/01/27
NDC:21695-814
Singapore Approved Products
RYTMONORM TABLET 150 mg
Manufacturer:Benta Lyon, Abbott Laboratories de Mexico S.A. de C.V.
Form:TABLET, FILM COATED
Strength:150 mg
Online:Yes
Approved: 1988/04/26
Approval:SIN00395P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath